GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Additional Paid-In Capital

Albert Labs International (XCNQ:ABRT) Additional Paid-In Capital : C$0.00 Mil(As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Additional Paid-In Capital?


Albert Labs International Additional Paid-In Capital Historical Data

The historical data trend for Albert Labs International's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Additional Paid-In Capital Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Additional Paid-In Capital
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Albert Labs International Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Albert Labs International Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International (XCNQ:ABRT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Additional Paid-In Capital
Comparable Companies
XCNQ:MYND XCNQ:ENBI TSXV:IBO XCNQ:HAVN XCNQ:GTTX XCNQ:MOOD XCNQ:WESA.X TSXV:BTI XCNQ:AGN XCNQ:CURE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Website
https://www.albertlabs.com
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines